C-type lectin SIGN-R1 has a role in experimental colitis and responsiveness to lipopolysaccharide

Journal of Immunology

Volumn 184, Issue 5, 2010, Pages 2627-2637

  Saunders, Sean P ^a   Barlow, Jillian L ^b   Walsh, Caitriona M ^a   Bellsoi, Agustin ^b   Smith, Philip ^a   McKenzie, Andrew N J ^b   Fallon, Padraic G ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; LECTIN; LECTIN RECEPTOR; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; PROTEIN SIGN R1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CD209 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; DEXTRAN SULFATE; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; COLITIS; COLON INJURY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EXPERIMENTAL STUDY; FEMALE; IN VIVO STUDY; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; WILD TYPE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COLON; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC PREDISPOSITION; GENETICS; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PERITONEUM MACROPHAGE; PHYSIOLOGY; SHOCK;

ANIMALS; CELL ADHESION MOLECULES; COLITIS; COLON; DEXTRAN SULFATE; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC PREDISPOSITION TO DISEASE; INTERLEUKIN-18; INTERLEUKIN-1BETA; INTERLEUKIN-6; LECTINS, C-TYPE; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, CELL SURFACE; SHOCK; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951891023     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901970     Document Type: Article

References (57)

1. Xavier, R. J., and D. K. Podolsky. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434. (Pubitemid 47123518)
2. Fukata, M., and M. T. Abreu. 2008. Role of Toll-like receptors in gastrointestinal malignancies. Oncogene 27: 234-243.
3. Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826. (Pubitemid 47598622)
4. Creagh, E.M., and L. A. O'Neill. 2006. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27: 352-357.
5. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
6. Underhill, D. M. 2007. Collaboration between the innate immune receptors dectin-1, TLRs, and Nods. Immunol. Rev. 219: 75-87.
7. van Kooyk, Y., and G. A. Rabinovich. 2008. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol. 9: 593-601.
8. van Kooyk, Y., and T. B. Geijtenbeek. 2003. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3: 697-709.
9. Gringhuis, S. I., J. den Dunnen, M. Litjens, B. van Het Hof, Y. van Kooyk, and T. B. Geijtenbeek. 2007. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity 26: 605-616.
10. Park, C. G., K. Takahara, E. Umemoto, Y. Yashima, K. Matsubara, Y. Matsuda, B. E. Clausen, K. Inaba, and R. M. Steinman. 2001. Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN. Int. Immunol. 13: 1283-1290.
11. Powlesland,A. S., E.M. Ward, S. K. Sadhu, Y. Guo,M. E.Taylor, and K. Drickamer. 2006. Widely divergent biochemical properties of the complete set of mouse DCSIGN-related proteins. J. Biol. Chem. 281: 20440-20449.
12. Nagaoka, K., K. Takahara, K. Tanaka, H. Yoshida, R. M. Steinman, S. Saitoh, S. Akashi-Takamura, K. Miyake, Y. S. Kang, C. G. Park, and K. Inaba. 2005. Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in gram-negative bacteria. Int. Immunol. 17: 827-836.
13. Geijtenbeek, T. B., P. C. Groot, M. A. Nolte, S. J. van Vliet, S. T. Gangaram-Panday, G. C. van Duijnhoven, G. Kraal, A. J. van Oosterhout, and Y. van Kooyk. 2002. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. Blood 100: 2908-2916.
14. Kang, Y. S., S. Yamazaki, T. Iyoda, M. Pack, S. A. Bruening, J. Y. Kim, K. Takahara, K. Inaba, R. M. Steinman, and C. G. Park. 2003. SIGN-R1, a novel C-type lectin expressed by marginal zone macrophages in spleen, mediates uptake of the polysaccharide dextran. Int. Immunol. 15: 177-186.
15. Taylor, P. R., G. D. Brown, J. Herre, D. L.Williams, J. A.Willment, and S. Gordon. 2004. The role of SIGNR1 and the β-glucan receptor (dectin-1) in the nonopsonic recognition of yeast by specific macrophages. J. Immunol. 172: 1157-1162.
16. Koppel, E.A., I. S. Ludwig, B. J.Appelmelk, Y. vanKooyk, and T. B. Geijtenbeek. 2005. Carbohydrate specificities of the murine DC-SIGN homologue mSIGNR1. Immunobiology 210: 195-201.
17. Lanoue, A., M. R. Clatworthy, P. Smith, S. Green, M. J. Townsend, H. E. Jolin, K. G. Smith, P. G. Fallon, and A. N. McKenzie. 2004. SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. J. Exp. Med. 200: 1383-1393.
18. Smith, P., N.E. Mangan, C.M. Walsh, R.E. Fallon, A. N. McKenzie, N. van Rooijen, and P. G. Fallon. 2007. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J. Immunol. 178: 4557-4566. (Pubitemid 46492408)
19. Cummins, E. P., F. Seeballuck, S. J. Keely, N. E. Mangan, J. J. Callanan, P. G. Fallon, and C. T. Taylor. 2008. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134: 156-165.
20. Mangan, N. E., N. van Rooijen, A.N. McKenzie, and P. G. Fallon. 2006. Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness. J. Immunol. 176: 138-147.
21. Yan, Y., V. Kolachala, G. Dalmasso, H. Nguyen, H. Laroui, S. V. Sitaraman, and D. Merlin. 2009. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One 4: e6073.
22. Qualls, J. E., A. M. Kaplan, N. van Rooijen, and D. A. Cohen. 2006. Suppression of experimental colitis by intestinal mononuclear phagocytes. J. Leukoc. Biol. 80: 802-815.
23. Hirschfeld, M., Y. Ma, J. H. Weis, S. N. Vogel, and J. J. Weis. 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol. 165: 618-622. (Pubitemid 30484724)
24. Kawasaki, K., S. Akashi, R. Shimazu, T. Yoshida, K. Miyake, and M. Nishijima. 2000. Mouse Toll-like receptor 4.MD-2 complex mediates lipopolysaccharidemimetic signal transduction by Taxol. J. Biol. Chem. 275: 2251-2254.
25. Bryant, C., and K. A. Fitzgerald. 2009. Molecular mechanisms involved in inflammasome activation. Trends Cell Biol. 19: 455-464.
26. Turner, J. R. 2009. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9: 799-809.
27. Ortega-Cava, C. F., S. Ishihara, M. A. Rumi, K. Kawashima, N. Ishimura, H. Kazumori, J. Udagawa, Y. Kadowaki, and Y. Kinoshita. 2003. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J. Immunol. 170: 3977-3985.
28. Fukata, M., A. Chen, A. Klepper, S. Krishnareddy, A. S. Vamadevan, L. S. Thomas, R. Xu, H. Inoue, M. Arditi, A. J. Dannenberg, and M. T. Abreu. 2006. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 131: 862-877. (Pubitemid 44316821)
29. Fukata, M., K. S. Michelsen, R. Eri, L. S. Thomas, B. Hu, K. Lukasek, C. C. Nast, J. Lechago, R. Xu, Y. Naiki, et al. 2005. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 288: G1055-G1065.
30. Kang, Y. S., J. Y. Kim, S. A. Bruening, M. Pack, A. Charalambous, A. Pritsker, T. M. Moran, J. M. Loeffler, R. M. Steinman, and C. G. Park. 2004. The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen. Proc. Natl. Acad. Sci. USA 101: 215-220.
31. Stevceva, L., P. Pavli, A. J. Husband, and W. F. Doe. 2001. The inflammatory infiltrate in the acute stage of the dextran sulphate sodium induced colitis: B cell response differs depending on the percentage of DSS used to induce it. BMC Clin. Pathol. 1: 3.
32. - dendritic cell populations in the colonic mucosa of patients with Crohn's disease. Eur. J. Immunol. 33: 143-151.
33. Silva, M. A., C. B. López, F. Riverin, L. Oligny, J. Menezes, and E. G. Seidman. 2004. Characterization and distribution of colonic dendritic cells in Crohn's disease. Inflamm. Bowel Dis. 10: 504-512.
34. Verstege, M. I., F. J. ten Kate, S. M. Reinartz, C. M. van Drunen, F. J. Slors, W. A. Bemelman, F. A. Vyth-Dreese, and A. A. te Velde. 2008. Dendritic cell populations in colon and mesenteric lymph nodes of patients with Crohn's disease. J. Histochem. Cytochem. 56: 233-241.
35. Iwasaki, A. 2007. Mucosal dendritic cells. Annu. Rev. Immunol. 25: 381-418.
36. Rioux, J. D., M. S. Silverberg, M. J. Daly, A. H. Steinhart, R. S. McLeod, A. M. Griffiths, T. Green, T. S. Brettin, V. Stone, S. B. Bull, et al. 2000. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am. J. Hum. Genet. 66: 1863-1870.
37. Núñez, C., J. Oliver, J. L.Mendoza, M. Gómez- García, C. Taxonera, L.M. Gómez, M. A. López-Nevot, E. G. de la Concha, E. Urcelay, A. Martínez, and J. Martín. 2007. CD209 in inflammatory bowel disease: a case-control study in the Spanish population. BMC Med. Genet. 8: 75.
38. + T cell effector function in a murine model of inflammatory bowel disease. J. Immunol. 180: 1886-1894.
39. Fukata, M., and M. T. Abreu. 2007. TLR4 signalling in the intestine in health and disease. Biochem. Soc. Trans. 35: 1473-1478.
40. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241. (Pubitemid 38962578)
41. Gaboriau-Routhiau, V., S. Rakotobe, E. Lécuyer, I. Mulder, A. Lan, C. Bridonneau, V. Rochet, A. Pisi, M. De Paepe, G. Brandi, et al. 2009. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31: 677-689.
42. Ivanov, I. I., K. Atarashi, N. Manel, E. L. Brodie, T. Shima, U. Karaoz, D. Wei, K. C. Goldfarb, C. A. Santee, S. V. Lynch, et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485-498.
43. Kang, J., and S. Rivest. 2007. MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis. J. Cell Biol. 179: 1219-1230. (Pubitemid 350277740)
44. Saba, K., K. Denda-Nagai, and T. Irimura. 2009. A C-type lectin MGL1/CD301a plays an anti-inflammatory role in murine experimental colitis. Am. J. Pathol. 174: 144-152.
45. Slack, E. C., M. J. Robinson, P. Hernanz-Falcón, G. D. Brown, D. L. Williams, E. Schweighoffer, V. L. Tybulewicz, and C. Reis e Sousa. 2007. Syk-dependent ERK activation regulates IL-2 and IL-10 production by DC stimulated with zymosan. Eur. J. Immunol. 37: 1600-1612.
46. Dennehy, K. M., J. A. Willment, D. L. Williams, and G. D. Brown. 2009. Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways. Eur. J. Immunol. 39: 1379-1386.
47. Gow, N. A., M. G. Netea, C. A. Munro, G. Ferwerda, S. Bates, H. M. Mora-Montes, L.Walker, T. Jansen, L. Jacobs, V. Tsoni, et al. 2007. Immune recognition of Candida albicans β-glucan by dectin-1. J. Infect. Dis. 196: 1565-1571.
48. Wieland, C.W., E. A. Koppel, J. den Dunnen, S. Florquin, A. N. McKenzie, Y. van Kooyk, T. van der Poll, and T. B. Geijtenbeek. 2007. Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis. Microbes Infect. 9: 134-141.
49. Saunders, S. P., C. M. Walsh, J. L. Barlow, N. E. Mangan, P. R. Taylor, A.N. McKenzie, P. Smith, and P.G. Fallon. 2009. The C-type lectin SIGNR1 binds Schistosomamansoni antigens in vitro, but SIGNR1-deficient mice have normal responses during schistosome infection. Infect. Immun. 77: 399-404.
50. Seki, E., H. Tsutsui, H. Nakano, N. Tsuji, K. Hoshino, O. Adachi, K. Adachi, S. Futatsugi, K. Kuida, O. Takeuchi, et al. 2001. Lipopolysaccharide- induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1b. J. Immunol. 166: 2651-2657.
51. Yu, H. B., and B. B. Finlay. 2008. The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe 4: 198-208.
52. Li, P., H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. McDowell, M. Paskind, L. Rodman, J. Salfeld, et al. 1995. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1b and resistant to endotoxic shock. Cell 80: 401-411.
53. Yamamoto, M., K. Yaginuma, H. Tsutsui, J. Sagara, X. Guan, E. Seki, K. Yasuda, M. Yamamoto, S. Akira, K. Nakanishi, et al. 2004. ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules. Genes Cells 9: 1055-1067.
54. Siegmund, B., H. A. Lehr, G. Fantuzzi, and C. A. Dinarello. 2001. IL-1β-converting enzyme (caspase-1) in intestinal inflammation. Proc. Natl. Acad. Sci. USA 98: 13249-13254.
55. Ferwerda, G., M. Kramer, D. de Jong, A. Piccini, L. A. Joosten, I. Devesaginer, S. E. Girardin, G. J. Adema, J. W. van der Meer, B. J. Kullberg, et al. 2008. Engagement of NOD2 has a dual effect on pro-IL-1β mRNA transcription and secretion of bioactive IL-1β. Eur. J. Immunol. 38: 184-191.
56. Sivakumar, P. V., G. M. Westrich, S. Kanaly, K. Garka, T. L. Born, J. M. Derry, and J. L. Viney. 2002. Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 50: 812-820.
57. Cario, E. 2008. Therapeutic impact of Toll-like receptors on inflammatory bowel diseases: a multiple-edged sword. Inflamm. Bowel Dis. 14: 411-421.